Back

Weight loss trials on CVD benefit.

26 August 2022 (13:30 - 13:40)
Organised by:
Congress Presentation Part of: Obesity and CV disease – Lowering CV risk with novel weight loss strategies Obesity and Diabetes Open Access ESC Congress 2022

5 More presentations in this session

Presentation thumbnail
Why do cardiologists need to manage obesity?
Professor J. Deanfield (London, GB)
Video
Presentation thumbnail
From pathophysiology to obesity management.
Professor L. Van Gaal (Edegem, BE)
Video
Presentation thumbnail
Novel anti-obesity drugs in weight management.
Professor H. Colhoun (Edinburgh, GB)
Video
Presentation thumbnail
Cases of multi-disciplinary obesity care in clinical practice.
Professor L. Van Gaal (Edegem, BE)
Video
Presentation thumbnail
Take home messages for cardiovascular practitioners.
Professor J. Deanfield (London, GB)
Video

Access the full session

Session thumbnail
Obesity and CV disease – Lowering CV risk with novel weight loss strategies
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 13:30 CET
You may be interested in
thumbnail
Webinar
Obesity management: implications for cardiovascular risk reduction
thumbnail
Congress Session
Obesity as a cardiovascular disease: integrated management
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources